• Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents In Chronic Hepatitis C Infection- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Pharmacoeconomics Analysis of Sertindole Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy

    Oct 1, 2017, 00:00

  • Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example

    Oct 1, 2017, 00:00

  • Reduced Needlestick Injuries And HBV Infections In Chinese Healthcare Workers From Blunt-Tip Suture Needles In Cesarean Sections- A Markov Simulation

    Oct 1, 2017, 00:00

  • Bayesian Methodology Considering Historical Data To Predict Overall Survival From Immature Trial Data In Oncology

    Oct 1, 2017, 00:00

  • Challenges in Optimising Real World Evidence for Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes- Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure

    Oct 1, 2017, 00:00

  • Seal or Varnish? Cost-Effectiveness of Fissure Sealants Versus Fluoride Varnish in Preventing Dental Decay in Children

    Oct 1, 2017, 00:00

  • Quality of Life for Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (PNF)

    Oct 1, 2017, 00:00

  • Economic Evaluation For Establishing Stroke Unit Followed By Early Supported Discharge In Egypt

    Oct 1, 2017, 00:00

  • Comparison Of Costs Between Hospital And Home Infusions In Patients Treated With Laronidase

    Oct 1, 2017, 00:00

  • Costo Efectividad Del USO De Ticagrelor Frente A Copidogrel En Pacientes CON Síndrome Coronario Agudo En Colombia

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In The Emergency Frequency At Patients With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease In The Spanish Region of Extremadura

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Arterial Hypertension In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Literature Review of The Cost of Dementia on China

    Oct 1, 2017, 00:00

  • Model Attention Improve The Hospital Nutrition Processes Under The Center Of Excellence Concept

    Oct 1, 2017, 00:00

  • Health Economics And Outcomes Research Needs Assessment For Latin America- Relationship Between Perceived And Expected Quality Of Knowledge In A Self-Assessment Survey

    Oct 1, 2017, 00:00

  • Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia- Development of Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • The Use of Real World Data for Nice Decision-Making- A Review of Submissions To Three Treatment Effectiveness Evaluation Programmes In 2015 And 2016

    Oct 1, 2017, 00:00

  • Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela

    Oct 1, 2017, 00:00

  • Economic Impact of Alirocumab In The Management of Primary Hypercholesterolemia or Mixed Dyslipidemia- An Italian Perspective

    Oct 1, 2017, 00:00

  • Positive Externalities of austerity? The Case of Smoking Cessation During the Financial Crisis in Greece

    Oct 1, 2017, 00:00

  • Analysis Of Epidemiological Data On Burden Disease In Europe

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Using Solifenacin And Modified-Release Tamsulosin Fixed Dose Combination for Treatment of Storage Symptoms Associated With Benign Prostatic Hyperplasia

    Oct 1, 2017, 00:00

  • Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease- Based On Korean National Insurnance Claims Data

    Oct 1, 2017, 00:00

  • Leveraging Electronic Health Records to Meet The Real World Evidence Needs of Hta- A Uk Perspective

    Oct 1, 2017, 00:00

  • Unmet Pharmaceutical Needs During The Economic Crisis In Greece

    Oct 1, 2017, 00:00

  • Influência Dos Fatores Socioeconômicos Na Incidência De Câncer De Mama- Revisão Sistemática

    Oct 1, 2017, 00:00

  • A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of ...

    Oct 1, 2017, 00:00

  • Uses and Applications of Eq-5d in Latin America the Caribbean- Systematic Review and Bibliometric Analysis

    Oct 1, 2017, 00:00

  • Extrapolation of Adult Data for Pediatric Drug Benefit Assessment In The Amnog Dossier In The Light of The New Amvsg

    Oct 1, 2017, 00:00

  • Treatment Patterns Among Newly Diagnosed Diabetes Patients in Dubai

    Oct 1, 2017, 00:00

  • Allowing Methadone’s Prescription To General Practitioners- A Positive Impact on The French Healthcare Insurance Expenditures

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of IVF Treatments Gonal-F® Versus HP-HMG in the United Arab Emirates (UAE)

    Oct 1, 2017, 00:00

  • Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil

    Oct 1, 2017, 00:00

  • Analysis of Oral Hypoglycemic Drugs Consumption in Ukraine in 2015

    Oct 1, 2017, 00:00

  • Value Of A Pilot Study In A Retrospective Chart Review- Final Protocol Design Should Base On Pilot Results

    Oct 1, 2017, 00:00

  • Comparative Analysis Of Health Technology Assessments Of Drugs For The Treatment Of Multiple Myeloma

    Oct 1, 2017, 00:00

  • Pro Instruments used in Studies of Pulmonary Hypertension Since 1960

    Oct 1, 2017, 00:00

  • Risk Factors of Asthma and Their Role in Triggering The Asthmatic Attack

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Prescription Patterns and their Impact on Outcome of Blood Pressure in Ethiopia-A Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • Custo De Tratamento Biológico Em Pacientes Com Doenças Reumáticas Em Uma Operadora De Saúde De Fortaleza/Ce

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Pembrolizumab for The First-Line Treatment of Metastatic Non-Small Cell Lung Carcinoma in Portugal

    Oct 1, 2017, 00:00

  • Exploring Factors Explaining Treatment Acceptance in Patients Suffering from a Chronic Disease

    Oct 1, 2017, 00:00

  • New European Medical Device Directive (MDD) Comes Into Effect In 2020- Chances And Consequences For Stakeholders

    Oct 1, 2017, 00:00

  • Multivariate Network Meta-Analysis of Survival Function Parameters

    Oct 1, 2017, 00:00

  • Improving Disease Detection Through Methods To Reduce Patient Heterogeneity

    Oct 1, 2017, 00:00

  • Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of A Physician-Implemented, Medication Screening Tool in Older Hospitalised Patients in Ireland

    Oct 1, 2017, 00:00

  • Copyright/Subscription

    Oct 1, 2017, 00:00

  • Assessing the Economic and Humanistic Burden of Psoriatic Arthritis in Brazil

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico

    Oct 1, 2017, 00:00

  • Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have “Full-Health” by EQ-5D-5L

    Oct 1, 2017, 00:00

  • The Choice of Effectiveness Criteria Affects Conclusions of Economic Evaluation of Health Care Innovations- Example Based on A Randomised Multicenter Trial Comparing Two Reduced Intensity Conditioning Regimen (FLU-BU-ATG) Vs. (FLU-TBI) For ...

    Oct 1, 2017, 00:00

  • A Systematic Review To Evaluate The Association Between Medication Adherence And Personality Traits

    Oct 1, 2017, 00:00

  • Which Are The Most Common Quality of Life Health States In Latin America? A Pareto Analysis of A Collaborative Project Using Euroqol Eq-5d In Argentina, Brazil, Chile and Uruguay

    Oct 1, 2017, 00:00

  • Increased Episode Rate of Medically-Attended Acute Gastroenteritis In Diabetics In England

    Oct 1, 2017, 00:00

  • Does Access To Highly Specialised Medicines Decline In A Northerly Direction?

    Oct 1, 2017, 00:00

  • Economic and Clinical Impact of Serum-Derived Bovine Immunoglobulin / Protein Isolate (SBI) in the Management of Chronic Diarrhea in Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • A Markov Microsimulation Model For The Economic Evaluation Of Partially Implantable Active Middle Ear Implants In Sensorineural Hearing Loss

    Oct 1, 2017, 00:00

  • Analysis Of The Behavior Of The Expenditure Curve In Oncology And Other Causes Of Death In The Last 5 Years Of Life – Brazil Real-World Health Care Data

    Oct 1, 2017, 00:00

  • The Cost Of Illness For Invasive Meningococcal B Disease In Germany

    Oct 1, 2017, 00:00

  • Quantifying the Trade-off Between Improved Glycemic Control and Severe Hypoglycemia Risk in Patients with Type 1 Diabetes- A Health Economic Analysis in the Uk

    Oct 1, 2017, 00:00

  • Establishing A Medication Error Reporting And Monitoring Programme In A Developing Country’s Tertiary Care Teaching Hospital

    Oct 1, 2017, 00:00

  • Estimating Survival After Radical Prostatectomy In Prostate Cancer; A Propensity-Score Matching Method

    Oct 1, 2017, 00:00

  • Evaluation Of Patient- (PRO) And Observer-Reported Outcomes (OBSRO) Measures Regarding Acceptability And Palatability Of Eltrombopag In A Pediatric Population

    Oct 1, 2017, 00:00

  • Pharmaceutical Care Workload And Workforce Requirement At Ministry Of Health Primary Care Centers During Ten Years Mass Gathering Hajj (2006-2015) In Makah Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • Systematic Literature Review of the Impact of Asthma Support Programs Dedicated to Adult Patients

    Oct 1, 2017, 00:00

  • The Cystic Fibrosis Impact Questionnaire (CF-IQ)- Qualitative Development And Cognitive Evaluation Of A New Patient-Reported Outcome Instrument To Assess The Life Impacts Of Cystic Fibrosis

    Oct 1, 2017, 00:00

  • Key Drivers In Health Technology Assessment By Analysing The Level Of Improvement In Actual Benefit In Solid Tumor Oncology Drugs

    Oct 1, 2017, 00:00

  • Comparison of The Long-Term Cost-Effectiveness of Ideglira Versus Multiple Daily Insulin Injections In The Spanish Setting Using Real-World Clinical Data

    Oct 1, 2017, 00:00

  • Programa Stewardship- Otimizando A Terapia Antimicrobiana Com Eficiência Em Um Hospital De Ensino De Referência Em Fortaleza, Ceará

    Oct 1, 2017, 00:00

  • Custos Diretos No Tratamento De Câncer De Mama- Olhar Estratégico De Uma Operadora De Planos De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • Orphan Drugs In The Uk, Do They Meet The Nice Highly Specialised Technology Threshold?

    Oct 1, 2017, 00:00

  • Utilization of Lipid-Lowering Drugs in Slovakia- Comparison of Data from Different Sources

    Oct 1, 2017, 00:00

  • Primary Nonadheren Do Differences Exist Between Life Sustaining And Quality Of Life Medications?

    Oct 1, 2017, 00:00

  • Reporting Of The Use Of Research And Publication Guidelines In Health Economic And Outcomes Research Publications In Inflammatory Bowel Disease – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Risk Factors Associated With Tuberculosis In Punjab, Pakistan

    Oct 1, 2017, 00:00

  • Demand And Supply Side Regulation Of Biosimilar Markets In Germany, France And England And Its Implications For Market Access Of Biosimilars

    Oct 1, 2017, 00:00

  • Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma

    Oct 1, 2017, 00:00

  • Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cobicistat-Boosted Darunavir In Hiv-Infected Patients In Mexico

    Oct 1, 2017, 00:00

  • Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Evaluating Health Impact Of Common Chronic Conditions On Quality Of Life Of EQ-5D-3L In Older Chinese

    Oct 1, 2017, 00:00

  • Drug Commercialization Before The Pricing And Reimbursement In Italy- The Non Negotiated C Class (C-NN)

    Oct 1, 2017, 00:00

  • Development Of A Descriptive System For Measuring Patient Experience

    Oct 1, 2017, 00:00

  • Cost-Utility Of Novel Tests After A Negative Prostate Biopsy

    Oct 1, 2017, 00:00

  • Social Burden of Copd

    Oct 1, 2017, 00:00

  • A Via Administrativa E Judicial Como Forma De Acesso Aos Medicamentos No Sistema Público De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Force Of Infection Of Helicobacter Pylori In Mexico- Evidence From A National Survey

    Oct 1, 2017, 00:00

  • Initiative To Obtain Advanced Therapeutic Outcomes In Multiple Myeloma (Importa Project)

    Oct 1, 2017, 00:00

  • Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

    Oct 1, 2017, 00:00

  • Target Organ Damage And The Long Term Effect of Nonadherence To Clinical Practice Guidelines In Patients With Hypertension- A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Cambio En La Carga De Enfermedad Ajustada Por Riesgo Para Una Población Afiliada A UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Using Network Meta-Analysis Of Individual Patient Data (IPD) Summary Aggregate Data (SAD) To Identify Which Combinations Of Interventions Work Best For Which Individuals

    Oct 1, 2017, 00:00

  • Exenatide In Obese Or Overweight Patients Without Diabetes- A Systematic Review And Meta-Analyses Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Detection And Management Of Diabetes In England- Results From The Health Survey For England

    Oct 1, 2017, 00:00

  • The Impact of Beliefs Towards Illness and Medications on Adherence and Clinical Outcomes in Acute Coronary Syndrome Patients in Hong Kong

    Oct 1, 2017, 00:00

  • Spirometry Comparison Between Smokers and Non-Smokers Students in University of Balochistan,Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Antibiotic Stewardship Policy in Biella General Hospital (Italy)- A Five-Year Surveillance

    Oct 1, 2017, 00:00

  • Estimating The Excess Costs of Community-Acquired Pneumonia In Elderly People In Japan

    Oct 1, 2017, 00:00

  • Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation Of Phid-CV Versus PCV-13 In Slovakia

    Oct 1, 2017, 00:00

  • Chronic Heart Failure (CHF) In The Czech Republic- Cost-of-Illness Analysis Disease Burden Based on Ahead Registry Data Mining

    Oct 1, 2017, 00:00

  • Determining The Brazilian Population Health Status- Estimate Of Health Production Function

    Oct 1, 2017, 00:00

  • Secukinumab is Dominant Vs. TNF-Inhibitors in the Treatment of Active Ankylosing Spondylitis- Results from a Turkish Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • Coverage Evidence Development in the Course of the Drug Reevaluation in Korea

    Oct 1, 2017, 00:00

  • Transfusion Trends In Primary and Revision Total Joint Arthroplasty- Are Recent Declines Shared Equally?

    Oct 1, 2017, 00:00

  • Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer- Qualitative Study Findings

    Oct 1, 2017, 00:00

  • Eating Habits and Physical Exercise Practices of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Health-Economics Evaluations in France, England, Canada and Autralia- Comparison of Methodologies and Impact on Drugs’ Access To Patients

    Oct 1, 2017, 00:00

  • Providing A Framework For Assessing Access To Medicine

    Oct 1, 2017, 00:00

  • The Economic Burden of Coeliac Disease in North America and Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • The Clinical and Cost-Effectiveness of Different Maternal Syphilis Screening Strategies in Brazil

    Oct 1, 2017, 00:00

  • Association Between Socioeconomic Deprivation And Cancer Incidence And Outcomes Among English CCGS

    Oct 1, 2017, 00:00

  • Evaluating the Long-Term Impact of Improving Care for Patients with Type 2 Diabetes in China

    Oct 1, 2017, 00:00

  • Evaluation of Barriers To Effective Insulin Therapy Among Type 2 Diabetes Mellitus Patients

    Oct 1, 2017, 00:00

  • Direct Costs of Long-Term Psychiatric Hospitalization in Public Hospital of the State of Sao Paulo, Brazil- The Complexo Hospitalar Juquery Case

    Oct 1, 2017, 00:00

  • Do Characteristics of Patients Influencing the Choice of Pain Treatment by GPS Differ in Osteoarthritis and Cancer? – An Italian Real World Evidence Study

    Oct 1, 2017, 00:00

  • What Are The Images Used To Diagnose And Assess Suspected Strokes?- A Systematic Literature Review Of Care In Four European Countries

    Oct 1, 2017, 00:00

  • Health Service Implications Of The Implementation Of An Early Discharge Strategy For Patients Admitted In Infectious Diseases Departments In Southern Europe

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole in The Prophylaxis of Invasive Fungal Infections in Acute Leukemia Patients in Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of The Sufentanil Sublingual Tablet System Vs Iv Pca Morphine For The Treatment of Acute Moderate To Severe Post-Operative Pain In Ireland

    Oct 1, 2017, 00:00

  • Application Study of the EQ-5D-5L in Oncology- Linking Self-Reported Quality of Life of Patients with Metastatic Colorectal Cancer to Clinical Data from a German Tumor Registry

    Oct 1, 2017, 00:00

  • Pro-Ctcae Impact on Payer Evaluations of Oncologic Therapies- A Qualitative Research Study

    Oct 1, 2017, 00:00

  • Direct Costs of Health Care of Cystic Fibrosis, The Case of A Health Insurer In Colombia

    Oct 1, 2017, 00:00

  • Low Density Lipoprotein Cholesterol (LDL-C) Target Goal Achievement Rate According to Physicians’ Compliance to Established Clinical Guidelines from National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) and American Colleg ...

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Oncology – Are we Getting Better?

    Oct 1, 2017, 00:00

  • Budget Impact Analysis For Switching From Manual To Pre-Filled Syringes For Catheter Maintenance

    Oct 1, 2017, 00:00

  • Regional Policies Impact on Biosimilar Adoption For Autoimmune Diseases In Italy

    Oct 1, 2017, 00:00

  • Quality of Life of Pregnant Women in Russian Federation

    Oct 1, 2017, 00:00

  • Special Considerations for Conducting Qualitative Interviews With Cancer Patients and Their Caregivers for The Purpose of Developing Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Preliminary Results Of Benefits Study - Brazilian Economic Evaluation Of Sflt-1/Plgf Test For Preeclampsia Prediction And Diagnosis- Private Perspective

    Oct 1, 2017, 00:00

  • Mapping Acroqol Scores to EQ-5D to Obtain Utility Values for Patients with Acromegaly

    Oct 1, 2017, 00:00

  • Newly Diagnosed Multiple Myeloma (NDMM) Patient Profiles; Findings From An Observational Chart Review In France, Germany, Italy, Spain And The United Kingdom

    Oct 1, 2017, 00:00

  • Economic Evaluations of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain- A Systematic Review

    Oct 1, 2017, 00:00

  • MÉTODOS DE ANÁLISE MULTICRITÉRIO EMPREGADOS NA SELEÇÃO DE MEDICAMENTOS

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence

    Oct 1, 2017, 00:00

  • Inconclusive Eviden Can Pharmacoeconomics Tilt The Balance?

    Oct 1, 2017, 00:00

  • Comparing Quality of Life of (RT-PA) with No-(RT-PA) in Stroke Attacked Patients

    Oct 1, 2017, 00:00

  • Estimating The Drug Treatment Cost of Breast Cancer

    Oct 1, 2017, 00:00

  • Horizon Scanning In Oncology – Rapid Scanning Approach In Slovakia

    Oct 1, 2017, 00:00

  • Antecipação Ao Rol De Procedimentos Da Agência Nacional De Saúde Suplementar- Impacto Orçamentário Da Incorporação De Um Novo Inibidor De Tirosina-Quinase

    Oct 1, 2017, 00:00

  • The Role of Stakeholder Engagement in E-Health and the use of Big Data to Predict Health Outcomes

    Oct 1, 2017, 00:00

  • Time To Market Access For Oncology Medicines In Gree Has It Changed During The Crisis?

    Oct 1, 2017, 00:00

  • Comparison Of Costs And Care Of Lung Cancer Patient At The End-Of-Life In Germany Depending On The Time Of Survival After Diagnosis

    Oct 1, 2017, 00:00

  • Cost Saving Analysis of Encephalogram Bispectral Index Monitoring (Bis) During Ten Different Types of Elective Surgeries in Colombia

    Oct 1, 2017, 00:00

  • Prescription Analysis on Off-Label Drugs In Pediatric Patients Using The Claims Data of The National Health Insurance In Korea

    Oct 1, 2017, 00:00

  • Longitudinal Study into the Dispensing Patterns of Benzodiazepines and Z-Drugs in a South African Private Healthcare Setting

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Enzalutamide and Abiraterone for Treatment of Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2017, 00:00

  • An Empirical Analysis of The Role of Learning by Doing in Dynamic Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Factors Affecting Polypharmacy in Elderly Patients with Diabetes in Greece

    Oct 1, 2017, 00:00

  • Social And Financial Impact Of Dravet Syndrome

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Brazil

    Oct 1, 2017, 00:00

  • A Review Of Economic Evaluations Considering Screening Interventions For The Risk Assessment Of Venous Thromboembolism In Women Considering Combined Oral Contraceptives

    Oct 1, 2017, 00:00

  • Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma

    Oct 1, 2017, 00:00

  • Pharmacoepidemiological Survey Of Under- Five Antidiarrhea Drugs Utilization In A Tertiary Teaching Hospital In Enugu Metropolis Southeast Nigeria

    Oct 1, 2017, 00:00

  • Clinical Pharmacy Services And Workforce Requirements At Ministry Of Health Hospitals During Ten Years Mass Gathering Hajj (2006-2015) In Makah And Al-Medina Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • When The Outcome of An Appraisal Is Not Ni A Review Of Nice Appeals

    Oct 1, 2017, 00:00

  • Integrated 2 Screw De-Rotation/Compression, Cepahlo-Medulary Device Reduces Implant Related Complications and Improves Health Related Quality of Life in Patients with Intertrochanteric Fractures, A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Decision Analytic Modelling Methods For The Assessing The Effectiveness Of Treatment Sequences For Clinical And Economic Decision Making- A Methodological Review

    Oct 1, 2017, 00:00

  • Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

    Oct 1, 2017, 00:00

  • Characterising the Relative Impact of Established Cardiovascular Disease and Chronic Kidney Disease on Quality of Life in Diabetes Patients

    Oct 1, 2017, 00:00

  • What's the Reality of Real-World Evidence in Health Technology Appraisal?

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Patients Treated with Computer-Assisted External Ring Fixators- A Descriptive Analysis of Patient Demographics, Healthcare Untilization, And Costs In The U.S

    Oct 1, 2017, 00:00

  • Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2- A French Nationwide Cohort Of 100,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Cost-Utility Of Prasugrel Compared To Clopidogrel For Preventing Cardiovascular Events In Diabetic Patients With Acute Coronary Syndrome In Brazil

    Oct 1, 2017, 00:00

  • Economic Burden of Cardiovascular Disease In Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Maximum Difference Scaling To Enhance Insight In Qualitative Payer Research

    Oct 1, 2017, 00:00

  • Analysis of Consumption of Anti-TB Medicines in Ukraine During 2012-2016

    Oct 1, 2017, 00:00

  • Diagnosis Of Patients With Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • Evaluating Physicians’ Perception Of Limitations And Obstacles Against The Effectiveness Of “Audit And Feedback” And “Printed Educational Materials” Interventions On Prescribing Behavior- A Qualitative Study

    Oct 1, 2017, 00:00

  • Comparison of the Assessments and Recommendations Issued by Brazil’s Conitec and Canada’s Cadth for Select Oncology Drugs

    Oct 1, 2017, 00:00

  • First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer- A Cost-Effectiveness Analysis from A UK Healthcare Perspective

    Oct 1, 2017, 00:00

  • Use of Abiraterone And Enzalutamide In Metastatic Castration-Resistant Prostate Cancer In Routine Clinical Practice

    Oct 1, 2017, 00:00

  • Treatment Switching and Power of ITT and RPSFTM

    Oct 1, 2017, 00:00

  • Factors Associated with Medication Adherence in Korean Postmenopausal Osteoporosis(PMO)- Results from PMO Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • Hospital Burden 18 Months after Surgical Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • The Use of The Propensity Score In The Cost-Effectiveness Analysis of The Atrial Fibrillation Treatment

    Oct 1, 2017, 00:00

  • Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Do Countries With Similar GDPS And Health Expenditures Reimburse The Same Cancer Drugs?

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Of Novel Treatments For Advanced Melanoma- A Systematic Literature Review And Network Meta-Analysis Of Effectiveness And Safety Outcomes

    Oct 1, 2017, 00:00

  • Cross-Cultural Adaptation And Validation Of The PEDSQL Cardiac Module Version 3.0

    Oct 1, 2017, 00:00

  • Economic Impact Of Floseal In Cardiac Surgery From The Perspective Of The Mexican Institute Of Social Security (IMSS)

    Oct 1, 2017, 00:00

  • Analysing Uptake Of New Medicine Service In English Community Pharmacies

    Oct 1, 2017, 00:00

  • Biosimilars And Reference Biotechnologic Drugs- Comparison Of The Biosimilars’ Effect On Reference Drug’s Price For EU, USA And Turkey

    Oct 1, 2017, 00:00

  • Cost-Utility Of Liquid Chromatography -Tandem Mass Spectrometry (LC-MS/MS)-Based Urine Analyses To Improve Adherence To Antihypertensive Treatment

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis- A Canadian Perspective

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Pentaray High Density Mapping Catheter In Treatment Of Ventricular Tachycardia In Turkey

    Oct 1, 2017, 00:00

  • Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis

    Oct 1, 2017, 00:00

  • Facilitators and Barriers to Adult Vaccination in South East Asia and Latin America

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban In Prevention of Stroke And Systemic Embolism In The Czech Republic

    Oct 1, 2017, 00:00

  • Exploring The Efficacy And Safety of Radiofrequency Ablation In Patients With Spinal Metastases- A Systematic Review

    Oct 1, 2017, 00:00

  • An Observational Retrospective Cohort Database Study To Estimate Costs Regarding Immunoglobulin Use for Itp Treatment In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review Of Cases Around The World

    Oct 1, 2017, 00:00

  • Economic Benefits of SFLT-1/PLGF Testing for Preeclampsia in Colombia- A Fiver Year Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Risk of Dipeptidyl-Peptidase-4 (Dpp-4) Inhibitors On Site-Specific Cancer- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Current Situation And Development Of Chronic Diseases In China

    Oct 1, 2017, 00:00

  • The Real-World Impact Of Mild To Moderate Hypoglycemic Events In Portugal – Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison of Opoid Substitution Therapy Vs. Non-Pharmcologic Therapy In The State of Kuwait

    Oct 1, 2017, 00:00

  • Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City

    Oct 1, 2017, 00:00

  • Assessment of Economic Model Stability By Repeated One-Way Sensitivity Analysis

    Oct 1, 2017, 00:00

  • Pricing Pressures And Market Access Outcomes Of Advanced Therapy Medicinal Products (Atmps) In The Eu5

    Oct 1, 2017, 00:00

  • Prevalence of Cardiovascular Disease In Type 2 Diabetes- A Global Systematic Review

    Oct 1, 2017, 00:00

  • Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico

    Oct 1, 2017, 00:00

  • Treatment interruption of Biological Drugs in Rheumatoid Arthritis- An Assessment of Case-Reports

    Oct 1, 2017, 00:00

  • The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK)- An Interim Report

    Oct 1, 2017, 00:00

  • Cost Impact Analysis of Needlestick Injuries In India

    Oct 1, 2017, 00:00

  • A Healthcare Policy Study To Build A Roadmap for Rare Disease Management Under The Egyptian Healthcare System

    Oct 1, 2017, 00:00

  • Current and Potential Future Changes In The Methodology of Emerging Value Frameworks

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Major Lower Extremity Amputation Due to Musculoskeletal Tumors

    Oct 1, 2017, 00:00

  • Reporting Quality Transparency Of Published Network Meta-analysis. Is it Satisfactory?

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy

    Oct 1, 2017, 00:00

  • Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy

    Oct 1, 2017, 00:00

  • Safety of A Specific First Line Antiretroviral Regimen- A Review

    Oct 1, 2017, 00:00

  • Hepatitis C Virus- Determinants Of Patients’ Management Costs

    Oct 1, 2017, 00:00

  • External Validation of A Mapping Algorithm To Estimate Eq-5d-3l Utilities From Oxford Knee Score Responses

    Oct 1, 2017, 00:00

  • Treatment Of Patients With Rheumatoid Arthritis- Real World Population-Based Evidence From France

    Oct 1, 2017, 00:00

  • Assessing Uptake Of Medicine Use Reviews In English Community Pharmacies

    Oct 1, 2017, 00:00

  • Psoriasis (PSO) Patients’ Profile And Impact of The Disease on Patients’ Quality of Life and Work Productivity In A Real-Life Setting In Brazil

    Oct 1, 2017, 00:00

  • Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison

    Oct 1, 2017, 00:00

  • Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Evaluating The Use of Central Nervous System Stimulants Among Medical and Non-Medical Students

    Oct 1, 2017, 00:00

  • Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan- A Literature Review

    Oct 1, 2017, 00:00

  • Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC)- Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And Regorafenib

    Oct 1, 2017, 00:00

  • Variation In Health Technology Assessment And Reimbursement Decisions In England, France, And Germany- Spotlight On The Impact Of Uncertainty

    Oct 1, 2017, 00:00

  • Characteristics Of The Dietary Habits Of Cancer Patients And Structure Of Consumption Of Basic Food Products

    Oct 1, 2017, 00:00

  • Representing Uncertainty In Economic Evaluations- Getting More From PSA Results

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Daclizumab Beta Vs Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis Patients With Inadequate Response To Prior Treatment In Scotland

    Oct 1, 2017, 00:00

  • Knowledge And Confidence Of Healthcare Providers Working At Hospitals About Appropriate Prescribing For Geriatrics

    Oct 1, 2017, 00:00

  • Risk Adjustments In Economic Models - What Is Their Impact On Predicted Rates?

    Oct 1, 2017, 00:00

  • European Study on Acute Cough in Children- Results of Poland

    Oct 1, 2017, 00:00

  • Cost-Minimization Analysis Of HPV 16/18 Genotyping Test Versus HPV Reflex Genotyping For Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • Venous Thromboembolism Prophylaxis- Risk Assessment Compliance with Respected Patient Risk

    Oct 1, 2017, 00:00

  • Comorbidities in Multiple Sclerosis- A Descriptive Longitudinal Clustering Analysis of Healthcare Resource Utilization Among MS Patients in IBM Explorys Database

    Oct 1, 2017, 00:00

  • The Impact of Health Policy on The Pharmaceutical Supply Chain In France

    Oct 1, 2017, 00:00

  • A Societal Utility Study to Elicit Values for Adverse Events and Surgical Complications in Moderate to Severe Crohn’s Disease in UK

    Oct 1, 2017, 00:00

  • Blood Pressure Measuring Techniques, Examination of The Blood Pressure Values In Relation With The Operating Principle of The Device

    Oct 1, 2017, 00:00

  • Federal Spending on Infliximab in Brazil- An Analysis of Purchases from 2007-2015

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Psoriatic Arthritis (Psa) Patients May Result in Poor Health-Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Ziprasidone Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Clinical Evaluation of CEA , CA125, CA19-9 and CA72-4 In Gastric Cancer Patients With Adjuvant Chemotherapy

    Oct 1, 2017, 00:00

  • Rotavirus Vaccination May Reduce Acute Gastroenteritis Rates Across All Age Groups In England

    Oct 1, 2017, 00:00

  • Management Of Healthcare Priorities By Single Natural Resource Driven Economies In Emerging Markets During Commodity Price Fluctuations

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Radiofrequency Catheter Ablation Of Atrial Fibrillation Based On Real-World Data- Manual Or Robotic?”

    Oct 1, 2017, 00:00

  • Methods for Extracting Treatment Patterns for Renal Cell Carcinoma (RCC) from Social Media (SM) Forums Using Natural Language Processing (NLP) and Machine Learning (ML)

    Oct 1, 2017, 00:00

  • National Adoption of New Immunossupresants for Solid Organs and Stem Cells Transplantations

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Biological Therapies In Psoriasis Using Real World Evidence

    Oct 1, 2017, 00:00

  • The Practical Application of a Digital Therapeutic Education Platform for Cardiovascular Rehabilitation

    Oct 1, 2017, 00:00

  • What Time Do We Dine?”- A Cultural Study To Evaluate People’s Views Of Set Meal Times Across Countries

    Oct 1, 2017, 00:00

  • Functional Assessment After Treatment Of Upper Extremity Soft Tissue Sarcomas Using Structured Outcome Measures- A Systematic Review

    Oct 1, 2017, 00:00

  • Addressing Uncertainty In Wound Management Using A Modified Delphi Methodology

    Oct 1, 2017, 00:00

  • Use of Thalidomide In Erythematosus Lupus Treatment

    Oct 1, 2017, 00:00

  • Cost And Operational Efficiency Comparison Of An Integrated VS. A Multi-Step System For Extracorporeal Photopheresis In Germany

    Oct 1, 2017, 00:00

  • Reporting Clinical Outcomes In Tavi Registries

    Oct 1, 2017, 00:00

  • Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI)- Real World Evidence from 26 US Institutions

    Oct 1, 2017, 00:00

  • Factores Asociados A La Automedicación En Usuarios De Boticas Y Farmacias En Perú- Análisis De La Encuesta De Satisfacción De Los Servicios De Salud (ENSUSALUD) 2015

    Oct 1, 2017, 00:00

  • Burden of Disease for Psoriasis In Argentina, Brazil, Colombia and Mexico

    Oct 1, 2017, 00:00

  • HTA MCDA In The Treatment of Macular Edema

    Oct 1, 2017, 00:00

  • Α Systematic Review of Economic Evaluations of Biological Therapies for the Treatment of Ulcerative Colitis

    Oct 1, 2017, 00:00

  • POCT Cost Effectiveness Case Study On The Way To A Hb-Hta Unit

    Oct 1, 2017, 00:00

  • Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests

    Oct 1, 2017, 00:00

  • Drug Utilisation Study of Anti-Obesity Products Dispensed by Pharmacies in South Africa

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of High-Throughput, Non-Invasive Prenatal Testing For Fetal Rhesus D Status

    Oct 1, 2017, 00:00

  • Development Of A Mortality Risk Prediction Tool For Patients With Heart Failure Or Chronic Kidney Disease At Risk Of Hyperkalaemia

    Oct 1, 2017, 00:00

  • 2017 Black Box Amnog Rebates- What Is Driving The Rebates?

    Oct 1, 2017, 00:00

  • Relevance of Surgical Interventions for Treatment of Obstructive Sleep Apnea in Germany

    Oct 1, 2017, 00:00

  • Healthcare Resource Use And Economic Burden Attributable To Respiratory Syncytial Virus In The United States

    Oct 1, 2017, 00:00

  • Cancer Drugs In Algeria And Six Other Countries- A Cross-Country Price Comparison Study

    Oct 1, 2017, 00:00

  • Open Tibial Fractures With Segmental Defects- A U.S. Retrospective Database Analysis Examining 12-Month Post-Operative Patient Outcomes And Costs

    Oct 1, 2017, 00:00

  • Modelling the Societal Impact of Secukinumab in Patients with Psoriatic Arthritis in Germany

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Gender Inequality In Acute Gastro-Enteritis Rates In England

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products

    Oct 1, 2017, 00:00

  • Secondary Prevention Cardiovascular Patients In Ireland - Population Characteristics For Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • A Review of The Quality of Life and Educational Burden of Allergic Rhinitis on Adolescents

    Oct 1, 2017, 00:00

  • Resource Utilisation And Costs Associated With Intravenous Patient-Controlled Analgesia Morphine For Post-Operative Pain Management In A Teaching Hospital Setting In Ireland

    Oct 1, 2017, 00:00

  • A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian Cancer

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario De 2 Métodos De Screening De Cáncer De Cuello Uterino Basados En Test De Hpv En Argentina

    Oct 1, 2017, 00:00

  • Estimation Of Health-Related Quality Of Life (HRQOL) In Cancer Patients Utilising A Time-To-Death Analysis

    Oct 1, 2017, 00:00

  • Incidence of Psychiatric Disorders in Women WITH a Suspected But Unconfirmed Diagnosis of Breast or Genital Organ Cancer

    Oct 1, 2017, 00:00

  • Market Access of Advanced Therapy Medicinal Product (ATMP) In Europe- Lessons Learnt And Key Considerations for Future Success

    Oct 1, 2017, 00:00

  • Estimated Clinical Impact Of Two Oncologic Drug Shortages

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Burden of Cytomegalovirus Disease In Immunosuppressed Patients After Haematopoietic Cell Transplantation In England

    Oct 1, 2017, 00:00

  • The Epidemiology and Burden of Paediatric Multiple Sclerosis- Systematic Literature Review

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of A Live Vaccine To Aid in The Control of Salmonid Rickettsial Septicaemia (Srs) In Farmed Atlantic Salmon in Chile

    Oct 1, 2017, 00:00

  • Comparison of Utility Values Implemented in Disease Models of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • European Real World Data Sources To Characterise Flares In Patients With Systemic Lupus Erythematosus- A Review

    Oct 1, 2017, 00:00

  • Analyzing the Treatment Cost of Liver Cirrhosis from Healthcare Payer’s Perspective of Vietnam in 2015

    Oct 1, 2017, 00:00

  • Review Of The Reimbursement Environment For Advanced Therapeutic Medicinal Products (AtmpS) In The Uk

    Oct 1, 2017, 00:00

  • Hospitalisations Among A Cohort Of Patients With Heart Failure Versus An Age- And Sex-Matched Cohort Without Heart Failure In England- A Comparative Study Using Cprd Data

    Oct 1, 2017, 00:00

  • Impacto Económico En Las Patologías De Salud Mental, Neurológicas Y Demencias En Colombia

    Oct 1, 2017, 00:00

  • Comparison Of Post-Creation Procedures And Related Costs Between Traditional Surgical Versus A New Endovascular Approach To Creating An Arteriovenous Fistula- A Usrds Comparison

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia

    Oct 1, 2017, 00:00

  • Burden Of Ulcerative Colitis In Japan

    Oct 1, 2017, 00:00

  • Mixed Methods Evaluation of An Itch Numeric Rating Scale Among Adult and Adolescent Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Household Storage Of Medicines And Associated Factors In Tigray Region, Northern Ethiopia

    Oct 1, 2017, 00:00

  • The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • A Multi-Dimensional Assessment of the Conservative Technologies Used for the Treatment of Uterine Fibroids in Italy

    Oct 1, 2017, 00:00

  • Estudio De Costo- Consecuencia De Darbepoetina Alfa Para EL Tratamiento De Anemia Sintomática Derivada De La Enfermedad Renal Crónica En Colombia

    Oct 1, 2017, 00:00

  • Precision Cost-Effectiveness Analysis Of Radiofrequency Catheter Ablation In A Real-World Atrial Fibrillation Population

    Oct 1, 2017, 00:00

  • Innovative Contracting- Use Of Complex Managed Entry Agreements

    Oct 1, 2017, 00:00

  • Evaluación De Efectividad Y Seguridad De La Terapia Farmacológica Para EL Tratamiento De La Enfermedad De Parkinson Inicial Y Avanzada En Colombia

    Oct 1, 2017, 00:00

  • Incidence, Mortality And Treatment Of Melanoma In Poland In The Years 2012–2016

    Oct 1, 2017, 00:00

  • Emerging Markets Tiered Pricing- A Quantitative Assessment Of Local Affordability And Existing Price To Patient

    Oct 1, 2017, 00:00

  • Patterns In Working Days Lost By Parents Of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Supraciliary Micro-Stent Glaucoma Implant Combined With Cataract Surgery In Management Of Primary Open-Angle Glaucoma (POAG) From The Canadian Payer Perspective

    Oct 1, 2017, 00:00

  • Price Life Cycle Management Of Orphan Drugs In France

    Oct 1, 2017, 00:00

  • Analysis of Metastatic Breast Cancer Policies to Advance Access To Treatment in Latin America- Research Methodology and Approaches used to Survey the Current Policy Environment

    Oct 1, 2017, 00:00

  • Time Restricted Decisions In German Benefit Assessments – A Success Story?

    Oct 1, 2017, 00:00

  • Are We Prep-Ared For Differences Between Nice And SMC Decision Making?

    Oct 1, 2017, 00:00

  • Cost Analysis of Several Treatment Sequences Used for The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal- The Case for Cladribine Tablets

    Oct 1, 2017, 00:00

  • An Observational Cross-Sectional Database Study To Estimate Hospitalization Costs Related To Cardiovascular Disease In Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • Intestinal Parasitic Disease And Hygienic Conditions In Children- Diagnostic Evaluation For Prevention

    Oct 1, 2017, 00:00

  • Oncologic Pain Attitudes, Intensity And Treatment In Brazil

    Oct 1, 2017, 00:00

  • A Population-Based Study on Clinical Outcomes and Medical Costs of Laparoscopic Versus Open Surgery for Colon Cancer Patients in Taiwan

    Oct 1, 2017, 00:00

  • Fast-Track Medication Refill (FTMR) Service Could Be More Cost-Effective Than The Current Model Of Care In Hong Kong

    Oct 1, 2017, 00:00

  • Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

    Oct 1, 2017, 00:00

  • Systematic Review Of Statins Effectiveness In Prevention Secondary In Elderly

    Oct 1, 2017, 00:00

  • Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Servi 24-Month Results of a Prospective Cohort Study

    Oct 1, 2017, 00:00

  • An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

    Oct 1, 2017, 00:00

  • Estimating the Value of Patient Engagement Outcomes in Precision Medicine to Eliminate Health Disparities in US American Indian Tribal Communities- Discriminant Analysis

    Oct 1, 2017, 00:00

  • Mapping The Systematic Review Toolbox

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • Treatment Satisfaction Among Patients with Moderate-to-Severe Plaque Psoriasis in Brazil

    Oct 1, 2017, 00:00

  • A Modified Time Trade-Off Experiment In EQ-5D-3L Valuation With Fuzzy Health States Utilities

    Oct 1, 2017, 00:00

  • Patient Prefences in Colorectal Adenoma Surveillance

    Oct 1, 2017, 00:00

  • Development of a Screening Questionnaire to Detect Heavy Menstrual Bleeding in Women of Child-Bearing Age

    Oct 1, 2017, 00:00

  • The Effect Of Chronic Diseases, Financial Hardship And Personality Types In Patient's Medication Adherence

    Oct 1, 2017, 00:00

  • Socio-Ecological Contextual Factors Associated with Hypertension Medication and Control Among the Elderly in Three Middle-Income Countries (Albania, Brazil, and Colombia)

    Oct 1, 2017, 00:00

  • Knowledge Of Leptospirosis Among Malaysian Wet Market Sellers

    Oct 1, 2017, 00:00

  • The Economic Impact Of Providing Dengue Vaccination In The Workplace In Brazil

    Oct 1, 2017, 00:00

  • Judicialização Da Saúde No Brasil- Proximidade Dos Magistrados Com As Políticas Públicas De Saúde

    Oct 1, 2017, 00:00

  • Comparing Costs and Outcomes Between Coblation Technology And Mechanical Debridement In The Treatment of Knee Cartilage Lesions- A Cost-Effectiveness Analysis From A Us Payer Perspective

    Oct 1, 2017, 00:00

  • Outcomes in Contact Force Technology Use For Cardiac Ablation – Role of Procedure Volume

    Oct 1, 2017, 00:00

  • Integrated Care System For Hypertension In China- What The Cost Will Be For Government? A budget impact analysis

    Oct 1, 2017, 00:00

  • Applying Nice End Of Life Criteria In The ERA Of Drug Approvals Based On Single-ARM Trial Data

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Duragraft As A Vein Graft Treatment In Coronary Artery Bypass Grafting In Turkey

    Oct 1, 2017, 00:00

  • tackling Network Meta-Analysis Methodological Challenges- A Case Study On Biologic Treatments For Moderate To Severe Plaque Psoriasis In Children And Young People

    Oct 1, 2017, 00:00

  • Comparisons Of Healthcare Utilization And Cost Impact Of Managing Type 2 Diabetes Across The System Of Care In Medicare Beneficiaries

    Oct 1, 2017, 00:00

  • Caracterización Del Riesgo Cardiovascular Por Factores Asociados- Análisis De Base De Datos De UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Disclosing Traditional CM) Use to the Health Care Providers- A Qualitative Study Among Thalassemia Patients in Malaysia

    Oct 1, 2017, 00:00

  • A Real World Evidence Model To Compare Direct Oral Anticoagulants Safety Outcomes For Atrial Fibrillation Patients In Spain

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Comparison of Glasdegib Plus Low Dose ARA-C Versus A Hypomethylating Agent For Acute Myeloid Leukemia Patients Ineligible For Intensive Chemotherapy

    Oct 1, 2017, 00:00

  • A Fresh Look At The Predictors Of The Number Of HIV Cases In Turkey

    Oct 1, 2017, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients- A Real-World Study In Sweden

    Oct 1, 2017, 00:00

  • Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

    Oct 1, 2017, 00:00

  • Estimation of The Cost of Metastatic Melanoma in France Using Melbase Data

    Oct 1, 2017, 00:00

  • Cost of Ilness Analysis- A Comparison of The Costs of Drug Therapy for Patients with Prostate Cancer, Breast Cancer, Colon Cancer, Melanoma and Renal Cell Carcinoma in Moscow

    Oct 1, 2017, 00:00

  • Adherence Issues in Multiple Sclerosis Treatment- How Can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions?

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Obstructive Sleep Apnea Treatment Guidelines - Implementation Status In Oecd-Countries

    Oct 1, 2017, 00:00

  • Predictors Of Activity And Participation In People With Motor Neurone Disease, Multiple Sclerosis And Parkinson’s Disease

    Oct 1, 2017, 00:00

  • Structured Education Program For Injection Technique - Budget Impact Model

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life of Patients with Osteoporosis Treated with Teriparatide

    Oct 1, 2017, 00:00

  • Healthcare Costs Associated with Cervical Cancer, Precancerous Lesions, and Genital Warts Treatment in Taiwan

    Oct 1, 2017, 00:00

  • A Predictive Model To Include Uncertainty In Mean Health Utilities Estimation- Impact Of Social Class, Body Mass Index And Chronic Diseases

    Oct 1, 2017, 00:00

  • A Systematic Literature Review Of The Societal Costs And Consequences Of Heroin Addiction

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Pro Instruments Used in Studies of Skin Cancer Since 1960

    Oct 1, 2017, 00:00

  • A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)

    Oct 1, 2017, 00:00

  • Estudio De Costo-Efectividad E Impacto Presupuestal De Denosumab vs. Ácido Zoledrónico Para El Manejo De Metástasis Óseas En Pacientes Con Cáncer De Próstata En Colombia

    Oct 1, 2017, 00:00

  • Psoriasis Drugs in Europe - Market Access Decisions in Comparision Based on the Prismaccess Database

    Oct 1, 2017, 00:00

  • Willingness To Pay For Qaly In The Czech Republic Between 2013 And 2017- A Review

    Oct 1, 2017, 00:00

  • Economic Assessment of NT-PROBNP Test for Acute Heart Failure at Brazilian Private Payer Perspective

    Oct 1, 2017, 00:00

  • Burden of Genital Warts In Ecuador- An Observational Study

    Oct 1, 2017, 00:00

  • A Systematic Review Of Economic Evaluations In Robot-Assisted Hysterectomy Use For Cervical Cancer Compared With Open And Laparoscopic Surgery

    Oct 1, 2017, 00:00

  • Costo De La Diabetes Mellitus En El Sistema De Salud Colombiano

    Oct 1, 2017, 00:00

  • Listening to the “Patient Voice” to Improve Design and Interpretation of Secondary Analyses- An Example in Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Disease-Related Cost Burden In Patients Undergoing Sinus Surgery For Chronic Rhinosinusitis- A Claims-Based Analysis

    Oct 1, 2017, 00:00

  • ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer- Clinical And Budget Impact

    Oct 1, 2017, 00:00

  • Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Inflectra® Vs. Remicade® for Ankylosing Spondylitis in Germany

    Oct 1, 2017, 00:00

  • Palliative Care Services In Romania- Analysis Of Utilization, Funding And Coverage

    Oct 1, 2017, 00:00

  • How Much Sexual Violence Against Women Costs To Brazil?

    Oct 1, 2017, 00:00

  • Long Term Efficacy of Pertuzumab For HER2+ Metastasic Breast Cancer Ecuadorian Population

    Oct 1, 2017, 00:00

  • Anti-Thrombotic Therapy For Patients With Venous Thromboembolism In A Nationwide Health Plan

    Oct 1, 2017, 00:00

  • Enhancement Program For Couples Adjustment To Failed Assisted Reproductive Technology

    Oct 1, 2017, 00:00

  • Coverage-With-Evidence-Development (CED) In Germany- Status QUO

    Oct 1, 2017, 00:00

  • The Epidemiology Of Adult Immune (Idiopathic) Thrombocytopenic Purpura (ITP) In Finland- Resource Utilisation, Related Costs And Hospital Medication Associated With The Treatment Of Non-Splenectomised Adult Itp Based On Real World Data From ...

    Oct 1, 2017, 00:00

  • Evaluating The Real-Life Daily-Cost of Treatment With Antiepileptic Drugs In Fran A Study Based on The Combination Of French National Health Insurance Public Database, and The EMR LPD Private Database

    Oct 1, 2017, 00:00

  • What Do The Single Technology Appraisals of The Past Tell US About Fast-Tracking The Most Cost-Effective New Technologies In The Future?

    Oct 1, 2017, 00:00

  • Impact of Isocitrate Dehydrogenase (IDH) Status on the Performance Status and Quality of Life (QOL) of Glioblastoma Multiforme (GBM) Patients

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Budget Impact of New Therapies for Metastatic Melanoma in Italy

    Oct 1, 2017, 00:00

  • Second-Line Treatments For Advanced Gastric Cancer- A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

    Oct 1, 2017, 00:00

  • Economic Burden Of Hospitalized Diarrheal Disease In Bangladesh

    Oct 1, 2017, 00:00

  • Variation Trend of Annual Medical Cost Forseveralkinds of Malignant Tumors in China- Analysis Based on A Regional Public Health Insurance Claim Database (2011-2015)

    Oct 1, 2017, 00:00

  • Impact of Different Baseline Definitions on The Incidence of Relevant Outcomes Associated with Cancer Following An Advanced Non-Small Cell Lung Cancer (NSCLC) Diagnosis

    Oct 1, 2017, 00:00

  • Quality of Life and Economic Burden Among Chronic Obstructive Pulmonary Disease (Copd) Patients in Japan

    Oct 1, 2017, 00:00

  • The Burden Of Albinism- Creation Of A Questionnaire

    Oct 1, 2017, 00:00

  • Work Productivity in Brazilian Patients with Moderate-to-Severe Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Hepatitis A and Hepatitis B Recombinant Vaccine Adherence In The United States

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67 (current)
  • 68
  • 69
  • 70
  • »